Tag: Pfizer

Pfizer Inc. used the prominent J.P. Morgan Healthcare Conference to detail its future roadmap, but the market's response has been ...

Pfizer is demonstrating tangible progress in its strategic shift away from reliance on COVID-19 products. A combination of promising clinical ...

Pharmaceutical giant Pfizer has framed 2026 as a definitive transitional period. The company's latest financial projections for revenue and earnings ...

Pfizer shares enter the new week facing a complex set of signals. While the company is aggressively pursuing strategic growth ...

The pharmaceutical giant Pfizer is navigating a challenging start to 2026, caught in a crossfire of financial, regulatory, and competitive ...

Pharmaceutical titan Pfizer finds itself at a pivotal juncture. The era of spectacular pandemic-driven profits is receding, and the company ...

Pfizer shareholders faced a tense weekend as conflicting signals emerged about the pharmaceutical giant's future prospects. While some institutional investors ...

While Pfizer's share price has shown limited movement in recent sessions, significant activity is unfolding behind the scenes. Prominent financial ...

After being largely dismissed by investors due to plummeting COVID-19 revenue and looming patent expirations, pharmaceutical giant Pfizer is suddenly ...

Pfizer is making significant strides in reshaping its post-pandemic trajectory, with recent clinical trial results generating substantial excitement among investors. ...